Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1977-3-21
|
pubmed:abstractText |
Lysozyme [EC 3.2.1.17] was purified from human tears, serum, and urine of acute monocytic leukemia patients, renal disease patients, and residents in cadmium-polluted areas of Tsushima Island using an affinity adsorbent containing lysozyme-lysate of Micrococcus lysodeikticus cell walls as the ligand. By means of this procedure, leukemia lysozyme was purified 100- to 200-fold with an activity recovery of 80%. It was crystallized at pH 10. This purified preparation appeared homogeneous in disc electrophoresis and showed a specific activity 2.5-fold higher than that of crystalline lysozyme from hen egg-white. Tear lysozyme was also purified to a nearly homogeneous state while the enzymes from normal serum and urine of a nephrosis patient and of residents in cadmium-polluted area were still disc electrophoretically heterogeneous and showed low specific activity as compared with purified leukemia lysozyme.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0021-924X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
703-9
|
pubmed:dateRevised |
2007-12-19
|
pubmed:meshHeading |
pubmed-meshheading:1070487-Amino Acids,
pubmed-meshheading:1070487-Chromatography, Affinity,
pubmed-meshheading:1070487-Crystallization,
pubmed-meshheading:1070487-Humans,
pubmed-meshheading:1070487-Kidney Diseases,
pubmed-meshheading:1070487-Leukemia, Monocytic, Acute,
pubmed-meshheading:1070487-Muramidase,
pubmed-meshheading:1070487-Tears
|
pubmed:year |
1976
|
pubmed:articleTitle |
Affinity chromatographic purification of human lysozyme, with special reference to human leukemia lysozyme.
|
pubmed:publicationType |
Journal Article
|